Citation only
via OpenAlex
Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients
Inger Hjørdis Bleskestad, Inga Strand Thorsen, Grete Jonsson, Øyvind Skadberg, Harald Bergrem, Lasse G. Gøransson
European Journal of Endocrinology · 2015 · ▲ 36 citations
Abstract
BACKGROUND: Controversies exist whether disturbances in mineral and bone disorder (MBD) normalise or persist after kidney transplantation. We assessed markers of MBD in patients with well-functioning kidney transplants to minimise confounding by reduced transplant function. METHODS: In this cross-sectional study, 40 patients aged ≥18 years who received a first kidney transplant more than 10 years ago were included. A well-functioning transplant was defined as an estimated glomerular filtration rate (eGFR) ≥45 ml/min per 1.73 m(2). RESULTS: Median time since transplantation was 18.3 years (inter quartile range (IQR) 12.2-26.2). Albumin-corrected serum calcium levels were above upper limit of normal in 15% of the transplanted patients, and serum phosphate levels below lower limit of normal in 31%. The median levels of intact parathyroid hormone (iPTH) and intact fibroblast growth factor 23 (iFGF23) were significantly higher than that in a group of healthy volunteers (11.3 pmol/l (IQR: 8.7-16.2) vs 4.4 pmol/l (IQR: 3.8-5.9), P<0.001 and 75.0 pg/ml (IQR: 53.3-108.0) vs 51.3 pg/ml (IQR: 36.3-67.6), P=0.004 respectively). There was a non-significant reduction in soluble Klotho (sKlotho) levels (605 pg/ml (IQR: 506-784) vs 692 pg/ml (IQR: 618-866)). When compared with a control group matched for eGFR, levels of iPTH were significantly higher (P<0.001), iFGF23 had a non-significant trend towards higher levels and sKlotho towards lower levels. CONCLUSIONS: In long-term kidney transplant patients with well-functioning kidney transplants, we found inappropriately high levels of iPTH and iFGF23 consistent with a state of persistent hyperparathyroidism. We speculate that the primary defect, FGF23 resistance, has evolved in the parathyroid gland before transplantation, and persists due to long half-life of the parathyroid cells.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1530/eje-14-0457
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Bleskestad, I.H., Thorsen, I.S., Jonsson, G., Skadberg, �., Bergrem, H., & Gøransson, L.G. (2015). Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients. <em>European Journal of Endocrinology</em>. https://doi.org/10.1530/eje-14-0457
Vancouver
Bleskestad IH, Thorsen IS, Jonsson G, Skadberg �, Bergrem H, Gøransson LG. Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients. European Journal of Endocrinology. 2015. doi:10.1530/eje-14-0457.
BibTeX
@article{inger2015Solubl,
title = {Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients},
author = {Inger Hjørdis Bleskestad and Inga Strand Thorsen and Grete Jonsson and Øyvind Skadberg and Harald Bergrem and Lasse G. Gøransson},
journal = {European Journal of Endocrinology},
year = {2015},
doi = {10.1530/eje-14-0457},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nephrology Dialysis Transplantation 2012
Citation only
Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease
Journal of Investigative Medicine 2017
Citation only
Plasma S-Klotho is Related to Kidney Function and Predicts Adverse Renal Outcomes in Patients with Advanced Chronic Kidney Disease
Transplantation 2016
Citation only
Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant Recipients
Nephrology Dialysis Transplantation 2012
Open access · OA
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study
International Heart Journal 2016
Open access · OA
Arterial Stiffness Is Significantly Associated With Left Ventricular Diastolic Dysfunction in Patients With Cardiovascular Disease
Oslo University Hospital 2024
Open access · US-GOV